Evaluation of Herbal Drug for Hypoglycemic Activity in Normal, Hyperglycemic and Alloxan-Induced Diabetic Rabbits by N. M. Qadri et al.
Pak. J. Chem. 1(1):32-37, 2011                                                                                                                                              Full Paper 
ISSN (Print): 2220-2625 
ISSN (Online): 2222-307X 
*Corresponding Author                                                                               Received January 25
th2011, Accepted February 20
th 2011 
Evaluation of Herbal Drug for Hypoglycemic Activity in Normal, Hyperglycemic and 
Alloxan-Induced Diabetic Rabbits 
 
N. M. Qadri, Zakir-ur-Rehman, 
*H. A. Rizvi 
PCSIR Laboratories Complex, 
Karachi-75280, Pakistan 
*Department of Biochemistry, Jinnah University for Women,  
5-C, Nazimabad Karachi-74600, Pakistan. 
Email: 
*afrozrizvi@hotmail.com 
 
ABSTRACT 
The  herbal  drug  formulation  (Diabrid)  was  evaluated  for  hypoglycemic  activity  in  normal,  glucose-fed  hyperglycemic  and 
alloxan-induced diabetic rabbits. Fasting blood glucose level was determined prior to the drug administration in each group. Blood 
sugar was also determined at various time intervals after oral drug administration and compared with the reference drug, Gliben 
clamide. The data was statistically analyzed. No significant hypoglycemic effect was produced by the herbal test drug in alloxan-
induced diabetic rabbits. However, fasting blood glucose levels were significantly decreased in the normal animals within one 
hour after drug administration. The maximum hypoglycemic effect was noted within two hours. A significant hypoglycemic effect 
was observed in glucose-fed hyperglycemic rabbits. Diabrid at a dose of1000 mg/kg produced approximately the same effect as 
3.3 mg/kg Glibenclamide. The herbal drug did not produce any toxic effect at higher doses. The study suggests that Diabrid is a 
safe potential herbal medicine in the amelioration of hyperglycemia in Type-II diabetes. It has not shown any significant effect in 
insulin dependent diabetes mellitus (IDDM) animal model.  
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1. INTRODUCTION 
An important and active area of  modern research on medicinal plants is to analyze and identify the biologically active 
compounds and their molecular structures, which would provide data to formulate and manufacture the man-made 
drugs of high economic value. Although medicinal herbs are used since centuries for the treatment of various ailments, 
but  most  of  them  are  still  being  used  without  any  scientific  validation  for  their  safety  and  therapeutic  efficacy. 
Scientific studies would not only confirm the herapeutic value of these plants, but would also help to develop new 
innovative drug formulations of high efficacy and low toxicity. 
A number of medicinal herbs are described for the care and treatment of diabetes in ancient folklore medicine. 
Still today several herbal medicines are being prescribed for the management of diabetes mellitus in many developing 
countries of the world. Most of the people still rely on the traditional system of medicine, because of their therapeutic 
efficacy,  minimum  side  effects  and  affordable  cost.  However,  most  of  these  herbal  drugs  are  widely  prescribed 
without any scientific knowledge about their therapeutic and toxic effects. Although a number of herbs have been 
scientifically studied and proved to be hypoglycemic in man and animals by various authors
1-5, but only very few 
standard herbal antidiabetic drug formulations have been developed and evaluated for efficacy and safety
6,7. The 
search for effective and safe herbal drug formulations is the need of the day as many of the presently  available 
allopathic drugs have side effects in the long run. 
The present study is an attempt to evaluate a poly-herbal preparation, Diabrid, for its antidiabetic activity 
using rabbit as the diabetic animal model. This drug has been developed in our laboratory and is based on four 
medicinal plants having reported hypoglycemic activity. Each plant was, however, individually evaluated to confirm 
its efficacy and safety before the drug was formulated. The main herbal ingredients of Diabrid are: Gymnemasylvestre 
Roxb
8-10, Momordicacharantia Linn
11-14, Trigonela foenum-graceum Linn
15,3 and Eugenia jambolana Lam
16-19 .Clinical 
trials of Diabrid have also been undertaken on diabetic patients to confirm its efficacy and safety, the results of which 
would be communicated in near future. 
 
2. EXPERIMENTAL 
 
2.1 Preparation of Herbal Formulation (Diabrid) 
The  leaves  of  Gymnemasylvestre  R.  Br.(Asclepideceae)commonly  known  as  Gurmar,  the  fruits  of 
Momordicacharantia  (Cucurbitaceae),a  common  vegetable,  known  as  bitter  gourd  or  Karela,  seeds  of 
Eugeniajambolana  (Myrtaceae) commonly known as Jaman and seeds of Trigonelafoenum-graeceum ( apilinaceae) 
known as Mathi, were obtained from the local dealers of medicinal plants and were authenticated by the taxonomists 
of Applied Biology Research Centre of PCSIR Laboratories Complex, Karachi. All the ingredients were cleaned and 
well dried in shade at room temperature in the laboratory. The dried parts of the plants were grinded into fine powder 
separately and passed through a sieve of 70 mesh size. The residual coarse material was re-grinded and again sieved Pakistan Journal of Chemistry 2011 
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through a 70 mesh size sieve. The fine powders of Gymnemasylvestre leaves, Momordica charantiafruits, Eugenia 
jambolana seeds and Trigonelafoenum-graeceum seeds were accurately weighed, mixed thoroughly in 3:3:3:1 ratio, 
dried at 40ºC, cooled and kept in air tight containers. 
 
2.2 Standardization of Diabrid 
Authenticated sample of the dried Diabrid powder (200g) was extracted by Soxhlet extraction procedure with Hexane, 
Ethyl acetate, Chloroform and Methanol using 1 L of solvent in each case. The aqueous extract was prepared through 
maceration. The solvent was concentrated under reduced pressure and the extracted material was dried and weighed. 
The extracts were separated on pre-coated Silicagel 60F254 TLC plates and qualitative tests were performed to detect 
the presence of various compounds. The quantity of extract obtained with each solvent and the compounds detected 
are as under: 
 
2.2.1 Hexane Extract 
3.5 g (1.75 % of dry wt):Gave positive test for triterpenes, steroids and fatty acids. No nitrogenous compound was 
detected  
 
2.2.2 Ethyl Acetate Extract   
3.5 g (1.75 % of the dry wt.): Gave positive test for nitrogen containing compounds, steroids and alkaloids 
 
2.2.3 Chloroform Extract 
1.6 g (0.8 % of dry wt.): Gave positive test for alkaloids and amine like compounds 
 
2.2.4 Methanol Extract 
2.9 g (1.45% of the dry wt.): Gave positive test for carbohydrates, glycosides, alkaloids and amino acids 
 
2.2.5 Aqueous Extract 
4.4 g (2.2 % of the dry wt.): Gave positive test for saponin, monosaccharides, amino acids 
   
2.2.6 Ash Content 
6.528 % 
 
2.2.7 Trace Elements 
Mn (128.96 ppm), Zn (12.07 ppm), Cr (1.29 ppm),Cu (6.83 ppm) and Fe (334.22 ppm) 
 
2.2.8 HPLC Fingerprinting: 
The ethanol-water (1:1 v/v) extract was prepared and subjected to HPLC (Shimadzu) analysis using C18 column with a 
UV detector set at 280 nm. The spectrum was maintained as reference standard for batch comparison. 
 
The ethanol extracts of each individual plant, different solvent extracts of dried Diabrid powder and the crude poly-
herbal Diabrid powder, were also tested for their efficacy. It was observed that all plant extracts have shown glucose 
lowering activity up to certain extent (relatively higher in aqueous extract), but the highest activity was observed in the 
crude dried mixture of herbal formulation. This suggests that the active ingredients of plants, work synergistically 
towards glucose lowering effect in their natural environment, while a part of the activity is lost during extraction 
process. Therefore, the whole part of the plant was used in the herbal preparation. 
 
2.3 Experimental Animals 
The hypoglycemic studies of Diabrid were conducted on male adult, healthy rabbits weighing between 1.4–1.7 kg. 
They were fed cucumber, carrots, lucerne, grains and water adlibitum. All the experimental animals were kept in 
standard conditions in the animal house of Pharmaceutical Research Centre of PCSIR Laboratories Complex, Karachi 
in accordance with international Guidelines (NRC 1996). The animals were kept under quarantine for two weeks 
before starting the experiment. Fasting animals were deprived of food for at least 16 hours, but allowed free access to 
water.  For  toxicity  experiments,  male  and  female  albino  Wistar  rats  (Rattusnorvegieus)  were  used.  They  were 
maintained  at  standard  environmental  conditions  of  temperature,  relative  humidity  and  light  according  to  NRC 
Guidelines  (1996)  and  kept  under observation  for two  weeks  before the  experiment  was  started. They  were fed 
standard diet and water adlibitum. 
 
2.4 Acute Toxicity Study 
Any toxicity associated with the drug action of “Diabrid” was evaluated in normal adult albino Wistar rats. Thirty(30) 
normal, healthy adult albino Wistar rats (15 ma1es and 15females) weighing about 150-180 g were selected for theRizvi et al, 2011 
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study. They were kept under observation for 15 days prior to the start of the toxicity experiments. The animals were 
divided into five groups each having six animals (3 male and 3 female).After an overnight fast (approx. 16 hrs), the 
drug suspended in 10 ml distilled water was orally fed at a dose of 250, 500,1000 and 1500 mg/kg body weight in 
animals of Group-1 to Group-IV respectively. The animals of Group-V were kept as control and fed 10 ml distilled 
water as vehicle. The feeding was continued for 3 consecutive days and observed daily for any sign of toxic symptoms 
or any gross physical and behavioral changes, morbidity and mortality. They were kept in separate cages and further 
observed for 15 days. No sign of any toxic effect was observed. 
 
2.5 Determination of Blood Glucose 
Blood glucose was determined by the Test Strip Method using One Touch Blood Glucometer (Lifescane, Johnson & 
Johnson Co., California). It works on colorimetric method based on the enzyme glucose oxidase-peroxidase system 
and gives direct reading of glucose in mg% after calibration with standard strips provided with the equipment. 
 
2.6 Effect of Diabrid in Normal Rabbits 
Eighteen (18) healthy male adult rabbits were used for the experiment. The animals were divided into three groups, 
each consisted of six rabbits. Group-I was kept as vehicle control (negative control) and received 10 ml distilled water, 
while the animals of the Group-II and III received herbal drug (Diabrid) orally at a dose of 500 mg and 1000 mg/kg 
body weight respectively. All the animals were kept on fast overnight (16 hours approx.) and blood samples were 
collected before the commencement of an oral drug administration. The required dose for each animal was suspended 
in 10 ml distilled water and administered orally through feeding tube. Blood samples (0.2 ml) were collected just prior 
to (0 hour) and after 1, 2, 3 and 4 hours of drug administration for determination of blood glucose. 
 
2.7 Effect of Diabrid on Glucose-Fed Hyperglycemic Rabbits 
Twenty four (24) healthy male adult rabbits were used for the experiment. They were divided into four groups (I-IV) 
having six animals in each group. After an overnight fast blood samples were collected from the ear vein of the 
animals for determination of fasting blood sugar (0 hour). Glucose at a dose of 1.5 g/kg body weight was given orally 
to the  animals of all groups.  Group-I was  kept as untreated Diabetic Control. Group-II received reference drug, 
Glibenclamide, at a dose of 3.3 mg/kg body weight (Positive Control),while Group-III and IV received test drug, 
Diabrid, at a dose of 500 mg/kg and 1000 mg/kg body weight respectively. Blood samples were collected after 1, 2, 3, 
4 and 24 hours for determination of blood glucose. The percent glycemic change with respect to fasting blood sugar 
level was calculated for each group. 
 
2.8 Effect of Diabrid on Alloxan-induced Diabetic Rabbits 
Twenty  four  (24)  animals  were  used for  the  experiment.  Diabetes  was induced  in  all rabbits  by  intra-peritoneal 
administration of alloxan monohydrate ata dose of 150 mg/kg body weight in sterile normal saline, which causes 
permanent  necrosis  of  ß-cells  of  pancreas.  After  eight  days  blood  samples  were  drawn  and  glucose  levels  were 
determined  to  confirm  the  development  of  diabetes.  Animals  with  marked  hyperglycemia,  having  fasting  blood 
glucose levels greater than 350 mg/dl were selected and used for the study. 
Table-1: Effect of herbal drug formulation (Diabrid) on blood sugar level of normal rabbits 
Groups  Weight of 
animals (g)  Oral Dose  Blood Sugar Level (mg/dl) 
0 h  1 h  2 h  3 h  4 h 
Group 1 
(Control) 
 
1525 ± 30.96  10 ml distilled 
water 
108.67 ± 
2.56 
107.67 ±  
3.16 
(- 0.92) 
NS 
105.33 ± 
3.92 
(- 3.07) 
NS 
 
c103.33 ± 
4.43 
(- 4.91) 
b101.00 ± 
3.82 
(- 7.06) 
Group II 
(Test-1) 
 
1625 ± 30.96 
Diabrid 
500 mg/Kg body 
weight 
 
104.00 ± 
1.46 
a93.00 ± 
1.44 
(- 10.58) 
a90.00 ± 
1.77 
(- 13.46) 
a91.50 ± 
0.99 
(- 12.02) 
a90.66 ± 
1.36 
(- 12.83) 
Group 
III 
(Test-2) 
1600 ± 28.87 
Diabrid 
1000 mg/Kg body 
weight 
 
105.17 ± 
1.90 
a94.17 ± 
0.98 
(- 10.46) 
a88.50 ± 
0.76 
(- 15.85) 
a87.17 ± 
1.30 
(- 17.12) 
a85.00 ± 
1.59 
(- 19.18) 
Values are Mean ± SEM of six replicate samples. Values in parentheses represent% glycemic change compared with zero hour reading 
a = highly significant (p < 0.001) compared to the initial zero hour reading , b = significant (p < 0.01) compared to the initial zero hour reading 
c= significant (p < 0.05) compared to the initial zero hour reading, NS= Non-significant,10 ml distilled water was used as vehicle
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The rabbits were divided into four groups; each group consisted of six animals. After obtaining the fasting 
blood sugar values, Group-I was  maintained as Control Diabetic Group and received 10 ml distilled water. The 
animals of Group-II and III were administered herbal drug Diabrid at a dose of 500 mg and 1000 mg/kg body weight 
respectively. Group-IV (Positive Control) was given subcutaneous soluble insulin at a dose of 4 IU/Kg body weight. 
Blood samples (0.2 ml) were collected at 0, 1, 2, 3 and 4 hours after the oral administration of drug for determination 
of blood glucose. 
 
2.9 Statistical Analysis 
The results are represented as mean ± S.E.M. The data were statistically analyzed by paired sample T-Test at 95 % 
confidence  interval  of  the  difference  to  determine  the  level  of  significance.  P  values  ≤  0.05  were  considered 
significant. Statistics were calculated using SPSS for windows 14.0 software. 
 
3. RESULTS AND DISCUSSION  
The herbal drug, Diabrid, did not produce any morbidity or mortality on oral administration up to a dose of 1500 
mg/kg body weight. All the animals were found active and showed normal physiological activity during 72 hours of 
observation period. There was no gross behavioral change in any animal for further 2 weeks of observation. These 
results indicate that the drug is well tolerated by animals and no acute toxicity was observed up to a dose of 1500 
mg/kg body weight. The therapeutic dose of 1000 mg/kg body weight is considered to be safe for the management of 
diabetic condition. Much higher doses of similar other herbal products have been recommended due to their high 
tolerance and safety profile
,7,20.  
The test drug produced significant hypoglycemic activity in normal rabbits within one hour of its administration 
(Table-1). The blood glucose levels were further reduced in 2h, which were maintained in the subsequent hours and no 
hypoglycemic state was observed. The reason may be the normal self regulatory mechanism of the body to keep the 
carbohydrate level in homeostasis. This is a desirable feature as accidental overdose would not produce any serious 
hypoglycemic condition. The hypoglycemic activity exhibited by Diabrid is, however, time and dose dependent.    
The glucose lowering effect in normal animals, up to certain limit, was also observed by other research groups 
in many individual plants
16, 2,19 and herbal formulations
6. It seems that this herbal drug formulation may either possess 
insulin  like  activity;  possibly  due  to  Momordicacharantia  component
21or  it  stimulates  the  ß-cells  of  islets  of 
Langerhans in pancreas to produce insulin, which in turn lowers blood glucose level. Similar observations were also 
reported by other research groups
4, 22. 
The effect of the herbal preparation in diabetic animal model is provided in Table-2. In control group the 
fasting blood sugar level was increased up to 48.87% after glucose administration, while the increase was 38.30% in 
Diabrid (1000 mg/kg) treated group and 20.70% in Glibenclamide (Aventis Pharma) treated rabbits. The blood sugar 
Table-2: Effect of herbal drug formulation (Diabrid) on blood sugar levels in glucose-fed hyperglycemic rabbits 
Groups 
Weight of 
Animals 
(g) 
Oral Dose 
Blood Sugar Levels (mg/dl) 
0 h  I h  2 h  3 h  4 h 
24 h 
 
Group-I 
(Negative 
Control) 
1543 ± 
35.28  1.5 g Glucose  118.00 
± 1.73 
a175.67 ± 
1.31 
(+48.87) 
a161.33 ± 
1.58 
(+36.72) 
120.17 ± 
2.56 
(+1.84) 
NS 
a75.33 
± 1.98 
(-
36.16) 
a66.66 ± 
1.68 
(-43.51) 
Group-II 
(Positive 
Control) 
1675 ± 
21.41 
1.5 g  Glucose 
+3.3 mg 
Glibenclamide 
109.50 
± 0.88 
a132.17 ± 
1.08 
(+20.70) 
108.00 ± 
0.58 
(-1.37) 
NS 
a78.33 ± 
0.61 
(-31.17) 
a53.33 
± 0.66 
(-
51.30) 
a62.33 ± 
1.08 
(-43.08) 
Group-III 
(Test-1) 
1552 ± 
21.51 
1.5 g Glucose 
+ 500 mg Diabrid 
112.33 
±1.05 
a159.00 ± 
1.24 
(+41.55) 
a147.5 ± 
1.71 
(+31.31) 
b95.67 ± 
1.82 
(-14.83) 
a83.66 
± 1.80 
(-
25.52) 
a99.83 ± 
1.27 
(-11.13) 
Group-IV 
(Test-2) 
1605 ± 
28.61 
1.5 g Glucose 
+1000 mg 
Diabrid 
96.17 
±1.74 
a133.00 
±1.65 
(+38.30) 
a122.00 
±1.24 
(+26.86) 
a75.17 
±1.54 
(-21.83) 
a53.66 
±1.28 
(-
44.20) 
a67.83± 
1.58 
(-29.47) 
Values are Mean ± SEM of six replicate samples. Values in parentheses represent% glycemic change compared with zero hour reading 
a = highly significant (p < 0.001) compared to the initial zero hour reading, b = significant (p < 0.01) compared to the initial zero hour reading 
c= significant (p < 0.05) compared to the initial zero hour reading, NS= Non-significant,10 ml distilled water was used as vehicle
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returned to slightly above normal level in 3 hours in Control Group, in 2 hours in Glibenclamide treated group and 
shortly after 2 hours in Diabrid treated animals, which was maintained upto 24 hours. These studies suggest that the 
drug not only resists the initial increase of blood sugar after glucose administration but also brings down the increased 
sugar level in the normal range in about two hours which is maintained up to 24 hours  and no hypoglycemia is 
observed. The hypoglycemic effect of Diabrid at a dose of 1000 mg/kg can be compared to that of well known oral 
anti-diabetic drug, Glibenclamide (belonging to the group of sulfonylurea), administered similarly by oral route in 
glucose-fed hyperglycemic rabbits. However, its dose is relatively higher as compared to the pure active compound, as 
it is a crude preparation, but it may be taken safely without producing any toxic effect. It is interesting to note that the 
therapeutic  dose  of  herbal  drug  was  effective  to  decrease  the  hyperglycemic  level  without  producing  any 
hypoglycemic state; whereas Glibenclamide induced hypoglycemic condition. 
The herbal drug, Diabrid, fails to decrease blood glucose levels in alloxan induced diabetic animals, whereas 
insulin produced a typical hypoglycemic response (Table-2). Alloxan destroys β-cells of the islets of Langerhans in 
pancreas almost completely
23 and therefore, the availability of insulin is cut down, which creates a state of permanent 
diabetes. This suggests, that the herbal drug (Diabrid) works in the presence of insulin and decrease blood glucose 
level through stimulation of β-cells of the islets of Langerhans, if intact, to produce more insulin. Diabrid seems to 
work on the same mechanism as that of clinically used suphonylurea drug like Glibenclamide, which decrease blood 
glucose level by stimulating the β-cells to release insulin, by reducing the hepatic release of glucose or increasing the 
glycogen deposits in the liver and by diminishing the insulin resistance in normal animals. 
Diabrid  contains  Gymnemasylvestreleaves,  Momordicacharantiafruits,  Eugenia  jambolanaseeds  and 
Trigonelafoenum-graeceum seeds as its main ingredients. Gymnemasylvestre contains gymnemic acid, which is used 
to  inhibit  the  adrenohypophyseal  stress  response
24  and  the  hyperglycemic  response  to  adrenalin
25,  26  and  growth 
hormone
24. It may also help by increasing peripheral utilization of glucose. Eugenia jambolana seeds promote the 
release of insulin from pancreas
15 increasing the level of insulin and decreasing its degradation
15. Momordicacharantia 
fruits have been shown to increase peripheral utilization of glucose perhaps due to its insulin-like factor
21. The seeds 
of Trigonelafoenum-graeceum are also used for the treatment of Diabetes mellitus, although its mechanism of action is 
unknown. 
Although the exact mechanism of hypoglycemic effect of Diabrid is not known, it can be suggested, that the herbal 
ingredients may work synergistically to reduce blood glucose level. The possible mechanism by which this herbal 
drug produces hypoglycemic effect may be either through improving the insulin secretion capacity of the β-cells of 
pancreas  or  by  enhancement  of  peripheral  metabolism  of  glucose.  It  may  also  reduce  the  blood  glucose  levels 
indirectly through decreasing hepatic release of glucose or increasing glycogendeposits in liver, as well as inhibiting 
the adrenocorticotropic hormones antagonist to insulin. Whatever the mechanism of action may be, the present study 
suggests  the  potential  use  of  herbal  drug,  Diabrid,  in  the  treatment  of  non-insulin  dependent  diabetes  mellitus 
Table-3: Effect of Herbal Drug Formulation (Diabrid) on Blood Sugar Levels of Alloxan-Induced Diabetic Rabbits 
Groups  Weight of 
animals (g)  Oral Dose 
Blood sugar level (mg/dl) 
0 h  I h  2 h  3 h  4 h 
Group-1 
(Negative  
Control) 
1550 ± 18.26  10 ml distilled 
water 
377.00 ± 
5.48 
c381.33 ± 4.80 
(+1.15) 
376.33 ± 4.11 
(-0.18) 
NS 
376.33 ± 
5.30 
(-0.18) 
NS 
375.67 ± 
4.77 
(-0.35) 
NS 
Group-11 
(Test-1) 
1838 ± 13.02 
Diabrid 
500 mg/Kg 
body weight 
394.17 ± 
3.00 
393.66 ± 1.41 
(-0.13) 
NS 
395.17 ± 1.76 
(+0.25) 
NS 
392.33 ± 
1.20 
(-0.47) 
NS 
390.83 ± 
2.34 
(-0.85) 
NS 
Group-Ill 
(Test-2) 
1608 ± 23.86 
Diabrid 
1000 mg/Kg 
body weight 
398.66 ± 
1.60 
394.33 ± 1.58 
(-1.09) 
NS 
c392.83 ± 1.05 
(-1.46) 
397.00 ± 
1.34 
(-0.42) 
NS 
397.00 ± 
1.69 
(-0.42) 
NS 
Group IV 
(Positive Control)  1592 ± 20.07 
Insulin 
(4 IU) Intra-
muscular 
401.66 ± 
1.20 
a232.83 ± 2.97 
(-42.03) 
a106.83 ± 1.47 
(-73.40) 
a53.67 ± 
0.80 
(-86.64) 
404.5 ± 
3.03 
(+0.71) 
NS 
Values are Mean ± SEM of six replicate samples. Values in parentheses represent% glycemic change compared with zero hour reading 
a = highly significant (p < 0.001) compared to the initial zero hour reading, b = significant (p < 0.01) compared to the initial zero hour reading 
c= significant (p < 0.05) compared to the initial zero hour reading, NS= Non-significant,10 ml distilled water was used as vehicle Pakistan Journal of Chemistry 2011 
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(NIDDM) or Type-II maturity on set diabetes mellitus and holds immense potential for its standardization and clinical 
trials in type-II diabetic patients as a new herbal anti-diabetic agent
27, 28. 
Animal toxicity study has demonstrated that this herbal drug is a non-toxic material and can be used safely up to dose 
level 1000 mg orally as therapeutic agent for the treatment of Type-II Diabetes. The study further confirms the claims 
of traditional system of medicine, that the plants used in this preparation possess hypoglycemic activity and may be 
used for the treatment of diabetes. Further chemical, pharmacological and clinical studies are being carried out to 
isolate the active constituents and to elucidate the exact mechanism of anti-diabetic action of this poly-herbal drug. 
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